chr6-51856060-G-A

Variant summary

Our verdict is Benign. The variant received -7 ACMG points: 2P and 9B. PM1BP4_StrongBP6BS2

The NM_138694.4(PKHD1):​c.7744C>T​(p.Pro2582Ser) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000411 in 1,599,152 control chromosomes in the GnomAD database, including 6 homozygotes. In-silico tool predicts a benign outcome for this variant. 17/22 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars).

Frequency

Genomes: 𝑓 0.00062 ( 2 hom., cov: 34)
Exomes 𝑓: 0.00039 ( 4 hom. )

Consequence

PKHD1
NM_138694.4 missense

Scores

19

Clinical Significance

Conflicting classifications of pathogenicity criteria provided, conflicting classifications U:3B:5

Conservation

PhyloP100: 2.44

Publications

4 publications found
Variant links:
Genes affected
PKHD1 (HGNC:9016): (PKHD1 ciliary IPT domain containing fibrocystin/polyductin) The protein encoded by this gene is predicted to have a single transmembrane (TM)-spanning domain and multiple copies of an immunoglobulin-like plexin-transcription-factor domain. Alternative splicing results in two transcript variants encoding different isoforms. Other alternatively spliced transcripts have been described, but the full length sequences have not been determined. Several of these transcripts are predicted to encode truncated products which lack the TM and may be secreted. Mutations in this gene cause autosomal recessive polycystic kidney disease, also known as polycystic kidney and hepatic disease-1. [provided by RefSeq, Jul 2008]
PKHD1 Gene-Disease associations (from GenCC):
  • autosomal recessive polycystic kidney disease
    Inheritance: AR Classification: DEFINITIVE, SUPPORTIVE Submitted by: ClinGen, Myriad Women’s Health, Orphanet
  • polycystic kidney disease 4
    Inheritance: AR Classification: DEFINITIVE, STRONG Submitted by: Labcorp Genetics (formerly Invitae), G2P, Laboratory for Molecular Medicine, Genomics England PanelApp
  • Caroli disease
    Inheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -7 ACMG points.

PM1
In a hotspot region, there are 2 aminoacids with missense pathogenic changes in the window of +-8 aminoacids around while only 1 benign, 7 uncertain in NM_138694.4
BP4
Computational evidence support a benign effect (MetaRNN=0.0052398443).
BP6
Variant 6-51856060-G-A is Benign according to our data. Variant chr6-51856060-G-A is described in ClinVar as Conflicting_classifications_of_pathogenicity. ClinVar VariationId is 288719.
BS2
High Homozygotes in GnomAd4 at 2 AR gene

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
PKHD1NM_138694.4 linkc.7744C>T p.Pro2582Ser missense_variant Exon 49 of 67 ENST00000371117.8 NP_619639.3 P08F94-1

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
PKHD1ENST00000371117.8 linkc.7744C>T p.Pro2582Ser missense_variant Exon 49 of 67 1 NM_138694.4 ENSP00000360158.3 P08F94-1
PKHD1ENST00000340994.4 linkc.7744C>T p.Pro2582Ser missense_variant Exon 49 of 61 5 ENSP00000341097.4 P08F94-2

Frequencies

GnomAD3 genomes
AF:
0.000624
AC:
95
AN:
152148
Hom.:
2
Cov.:
34
show subpopulations
Gnomad AFR
AF:
0.000121
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.00196
Gnomad ASJ
AF:
0.0124
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.000207
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00633
Gnomad NFE
AF:
0.000132
Gnomad OTH
AF:
0.00239
GnomAD2 exomes
AF:
0.000764
AC:
192
AN:
251324
AF XY:
0.000670
show subpopulations
Gnomad AFR exome
AF:
0.00
Gnomad AMR exome
AF:
0.00116
Gnomad ASJ exome
AF:
0.0113
Gnomad EAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.000194
Gnomad OTH exome
AF:
0.00163
GnomAD4 exome
AF:
0.000390
AC:
564
AN:
1446886
Hom.:
4
Cov.:
30
AF XY:
0.000365
AC XY:
263
AN XY:
720932
show subpopulations
African (AFR)
AF:
0.0000302
AC:
1
AN:
33062
American (AMR)
AF:
0.00123
AC:
55
AN:
44682
Ashkenazi Jewish (ASJ)
AF:
0.0118
AC:
307
AN:
26062
East Asian (EAS)
AF:
0.00
AC:
0
AN:
39422
South Asian (SAS)
AF:
0.000210
AC:
18
AN:
85722
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
53414
Middle Eastern (MID)
AF:
0.00818
AC:
47
AN:
5744
European-Non Finnish (NFE)
AF:
0.0000564
AC:
62
AN:
1098988
Other (OTH)
AF:
0.00124
AC:
74
AN:
59790
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.482
Heterozygous variant carriers
0
32
63
95
126
158
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
10
20
30
40
50
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.000617
AC:
94
AN:
152266
Hom.:
2
Cov.:
34
AF XY:
0.000578
AC XY:
43
AN XY:
74448
show subpopulations
African (AFR)
AF:
0.000120
AC:
5
AN:
41546
American (AMR)
AF:
0.00196
AC:
30
AN:
15294
Ashkenazi Jewish (ASJ)
AF:
0.0124
AC:
43
AN:
3470
East Asian (EAS)
AF:
0.00
AC:
0
AN:
5186
South Asian (SAS)
AF:
0.000207
AC:
1
AN:
4820
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
10612
Middle Eastern (MID)
AF:
0.00340
AC:
1
AN:
294
European-Non Finnish (NFE)
AF:
0.000132
AC:
9
AN:
68018
Other (OTH)
AF:
0.00237
AC:
5
AN:
2114
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.477
Heterozygous variant carriers
0
5
10
16
21
26
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.000742
Hom.:
0
Bravo
AF:
0.000801
ESP6500AA
AF:
0.00
AC:
0
ESP6500EA
AF:
0.000349
AC:
3
ExAC
AF:
0.000494
AC:
60
EpiCase
AF:
0.000273
EpiControl
AF:
0.000178

ClinVar

Significance: Conflicting classifications of pathogenicity
Submissions summary: Uncertain:3Benign:5
Revision: criteria provided, conflicting classifications
LINK: link

Submissions by phenotype

Autosomal recessive polycystic kidney disease Uncertain:1Benign:2
Nov 14, 2017
Natera, Inc.
Significance:Benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

- -

Jan 12, 2018
Illumina Laboratory Services, Illumina
Significance:Uncertain significance
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score, this variant could not be ruled out of causing disease and therefore its association with disease required further investigation. A literature search was performed for the gene, cDNA change, and amino acid change (if applicable). No publications were found based on this search. This variant was therefore classified as a variant of unknown significance for this disease. -

Jan 06, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

not provided Uncertain:1Benign:1
Jan 01, 2017
CeGaT Center for Human Genetics Tuebingen
Significance:Uncertain significance
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Dec 02, 2021
GeneDx
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Autosomal dominant polycystic liver disease Uncertain:1
Sep 01, 2021
Laboratory of Gastroenterology and Hepatology, Radboud University Medical Center
Significance:Uncertain significance
Review Status:no assertion criteria provided
Collection Method:research

- -

not specified Benign:1
Jun 27, 2017
Eurofins Ntd Llc (ga)
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

PKHD1-related disorder Benign:1
Mar 29, 2021
PreventionGenetics, part of Exact Sciences
Significance:Benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

This variant is classified as benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.091
BayesDel_addAF
Benign
-0.33
T
BayesDel_noAF
Benign
-0.30
CADD
Benign
16
DANN
Benign
0.97
DEOGEN2
Benign
0.081
T;.
Eigen
Benign
-0.21
Eigen_PC
Benign
-0.27
FATHMM_MKL
Benign
0.66
D
LIST_S2
Benign
0.78
T;T
M_CAP
Benign
0.063
D
MetaRNN
Benign
0.0052
T;T
MetaSVM
Benign
-0.43
T
MutationAssessor
Benign
1.8
L;L
PhyloP100
2.4
PrimateAI
Benign
0.26
T
PROVEAN
Benign
-1.4
N;N
REVEL
Benign
0.26
Sift
Benign
0.99
T;T
Sift4G
Benign
0.11
T;T
Polyphen
0.98
D;D
Vest4
0.20
MVP
0.90
MPC
0.083
ClinPred
0.051
T
GERP RS
4.4
Varity_R
0.031
gMVP
0.69
Mutation Taster
=96/4
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.050
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs200204857; hg19: chr6-51720858; API